Abstract:BACKGROUND: The impact of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation on the relationship between plasma homocysteine (Hcy) levels and stroke has been extensively studied and documented in previous study. However, it remains unclear whether the MTHFR C677T mutation can affect the response to Hcy lowering treatment in stroke patients with hyperhomocysteinemia (HHcy). Understanding the impact of genetic factors on treatment response can help optimize personalized treatment strategies for stroke patients with HHcy. We aimed to investigate the potential association between the MTHFR C677T gene polymorphisms and the effectiveness of Hcy lowering treatment using vitamin therapy in stroke patients with HHcy.METHODS: The MTHFR C677T genotype polymorphisms were identified using polymerase chain reaction-restriction fragment length polymorphism, and the distribution of three genotypes in the MTHFR C677T gene locus was compared. The treatment effects of Hcy lowering agents were compared among patients with different genotypes.RESULTS: Among the 320 stroke patients enrolled in the study, 258 (80.6%) were diagnosed with HHcy. Of these, 162 patients (Effective Group) responded well to the clinical Hcy lowering treatment, while 96 patients (Invalid Group) failed to achieve sufficient response even after taking combination supplements of folic acid, Vitamin B6, and methylcobalamin for one month. Significant differences were observed in terms of age (p < 0.001), hypertension (p = 0.034), dyslipidemia (p = 0.022), hyperuricemia (p = 0.013) and genotype distribution of MTHFR C677T gene polymorphism (p < 0.001) between the Invalid group and the Effective group. The multivariate regression analysis revealed that the T allele (odd rations [OR], 1.327; 95% confidence interval [CI], 1.114-1.580; p = 0.0015) was independently associated with an insufficient Hcy lowering treatment effect. Additionally, the TT genotype was independently associated with insufficient response in both the codominant model (OR, 1.645; 95% CI, 1.093-2.476; p = 0.017) and the recessive model (TT versus CC + CT; OR, 1.529; 95% CI, 1.145-2.042; p = 0.004). However, no relationship was observed between CT + TT genotypes and poor treatment effect in the dominate model.CONCLUSIONS: Our findings suggested that the TT genotype and T allele of MTHFR C677T polymorphism were independently associated with an insufficient Hcy lowering treatment effect in stroke patients with HHcy.

Abstract WP251: Dietary Methionine and Homocysteine Level Interaction and Recurrent Stroke

Genome-Wide Meta-Analysis of Homocysteine and Methionine Metabolism Identifies Five One Carbon Metabolism Loci and a Novel Association of ALDH1L1 with Ischemic Stroke

Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial.

High MTHFR Promoter Methylation Levels in Men Confer Protection Against Ischemic Stroke

The U-Shaped Relationship Between Serum Methylene Tetrahydrofolate Reductase And Large-Artery Atherosclerotic Stroke

Methylenetetrahydrofolate Reductase C677t Polymorphism, Hypertension And Risk Of Stroke: A Prospective, Nested Case-Control Study

Abstract MP13: Plasma Homocysteine is Causally Associated With Ischemic Stroke in a Han Chinese Population: A Mendelian Randomization Study

High Plasma Homocysteine Levels Contribute to the Risk of Stroke Recurrence and All-Cause Mortality in a Large Prospective Stroke Population.

Homocysteine and Stroke Risk

Association Between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis.

Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia

[Hyperhomocysteine, Methylenetetrahydrofolate Reductase Gene, and Other Risk Factors in Ischemic Stroke].

Interaction of serum vitamin B<sub>12</sub> and folate with <i>MTHFR</i> genotypes on risk of ischemic stroke

Single nucleotide polymorphism of MTHFR rs1801133 associated with elevated Hcy levels affects susceptibility to cerebral small vessel disease

Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke.

A Mendelian Randomization Study of Plasma Homocysteine and Ischemic Stroke in a Han Chinese Population.

The relationship of plasma homocysteine levels and polymorphism in homocysteine metabolism related enzymes with brain stroke

Genetically predicted plasma levels of amino acids and stroke risk: a Mendelian randomization study

Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence

Methylenetetrahydrofolate Reductase C677T Polymorphism, Hypertension, and Risks of Stroke: A Prospective Nested Case–control Study

MTHFR and Risk of Stroke and Heart Disease in a Low-Folate Population: a Prospective Study of 156 000 Chinese Adults.